Siwa Therapeutics
Get Full AccessDescription
- SIWA Therapeutics is a privately held preclinical stage biotechnology company that has a monoclonal antibody that targets and destroys senescent cells. Our current therapeutic focus is on certain rare and fast track diseases, including cancer metastasis and muscle wasting diseases, such as muscular dystrophy. Beyond these indications, senescent cells are causally implicated in a wide variety of diseases including: neurodegenerative diseases; autoimmune conditions, and infectious diseases. SIWA is currently optimizing its lead antibody, SIWA 318, and in parallel, seeking partnerships to advance SIWA 318 and other related technologies to broaden and accelerate its development pipeline.
-
Headquarters:400 East Randolph Street Suite 705, Chicago, Illinois, United States
More -
Phone Number:
-
Website: https://www.siwatherapeutics.com
-
Employees:7
-
Revenue:$1 - 10M
-
Legal Name:Siwa Therapeutics
-
Siwa Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Siwa Therapeutics
-
Where are Siwa Therapeutics's Headquarters?
Siwa Therapeutics's Headquarters are in 400 East Randolph Street Suite 705,Chicago,Illinois,United States
-
What is Siwa Therapeutics's official website?
Siwa Therapeutics's official website is https://www.siwatherapeutics.com
-
What is Siwa Therapeutics's Revenue?
Siwa Therapeutics's revenue is $1 - 10M
-
What is Siwa Therapeutics's NAICS code?
Siwa Therapeutics's NAICS code is 541713
-
How many employees are working in Siwa Therapeutics
Siwa Therapeutics has 7 employees
-
What is Siwa Therapeutics's Industry?
Siwa Therapeutics is in the industry of Biotechnology
-
Who is Siwa Therapeutics's CEO?
Siwa Therapeutics's CEO is Lewis Gruber
-
Who is Siwa Therapeutics's Chief Administrative Officer?
Siwa Therapeutics's Chief Administrative Officer is Misty Gruber

